One of the topics at the Drug Security Forum held during the opening day of SPIEF 2023 was new technologies as the basis of contemporary treatment methods for diabetes mellitus. The event was organized by the Roscongress Foundation and the Ministry of Health of the Russian Federation, with the support of the Subcommittee on Drug Circulation and the Development of the Pharmaceutical and Medical Industry of the State Duma Committee for Health Protection
Panelists at the event included Director of the National Medical Research Center for Endocrinology of the Ministry of Health of the Russian Federation Natalia Mokrysheva; Director of the Russian Children’s Clinical Hospital of the Russian National Research Medical University named after N.I. Pirogov Elena Petryaykina; Rector of Pirogov Russian National Research Medical University Sergei Lukyanov; President of the Russian Diabetes Association Gagik Galstyan; Medical Director of Medscan Group Svetlana Kanevskaya; Vice-Rector of Economics and Development of the Russian Medical Academy of Continuous Professional Education Arkady Goldberg; Director of the GEROPHARM Research Centre Roman Dray; President of the “Don’t Be Afraid” Project of the Regional Public Organization for Assistance to Patients with Epilepsy Vasily Generalov; Head of the Help First Project Tamara Kozyreva; and Doctor of the Russian Mini-Football Team for People with Diabetes, Head of the Author’s Online Diabetes School Bulat Valitov.
In Russia, the number of patients with diabetes has increased 2.5-fold over the past 20 years. The rapid development of modern medicine has opened up new opportunities in the diagnosis and treatment of this complex disease. The development of molecular genetic research has made it possible to improve diagnosis and adopt a personalized approach to treatment. The use of modern antidiabetic drugs helps prevent the development of acute complications and delay the development of cardiovascular complications in type II diabetes. The development of drugs for immunotherapy of type I diabetes is under way. The emergence of new medical devices and digital technologies, including continuous glucose monitors, smart insulin pens, feedback-enabled insulin pumps, personal health assistants, mobile apps, telemedicine services, and AI systems have significant potential to improve the quality of care and treatment outcomes. Technologies such as bionic or artificial pancreas are expected in the future, with high hopes for the application of stem cell technologies.
“Diabetes mellitus is one of the three leading illnesses that lead to disability and death,” notes the session’s moderator, First Deputy CEO for Development and Director of the Healthcare Directorate of the Roscongress Foundation Anastasia Stolkova. “Morbidity is on the rise, adding to the already significant burden on the economy and the healthcare system. If we want to reduce the number of cases and improve early detection of the disease, then we need to carry out information campaigns to raise awareness about diabetes.” Stolkova praised the high level of scientific achievements in the development of methods for controlling and treating diabetes mellitus, and also expressed the hope that new methods for preventing the disease would be discovered in the near future.
The panelists discussed innovative technologies for treating diabetes that are currently available in the world and accessible in Russia, promising new medicines and medical devices that are being developed in Russia, the technologies that are in the greatest demand, how to accelerate the introduction of digital technologies into diabetes mellitus treatment maps, and which foreign practices should be adopted in Russia.
